SEARCH

SEARCH BY CITATION

References

  • 1
    Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham, D.M., Kuttesch, J.F., Andreeff, M., Bates, S.E., Berard, C.W., Boyett, J.M., Brophy, N.A., Broxterman, H.J., Chan, H.S.L., Dalton, W.S., Dietel, M., Fojo, A.T., Gascoyne, R.D., Head, D., Houghton, P.J., Srivastava, D.K., Lehnert, M., Leith, C.P., Paietta, E., Pavelic, Z.P., Rimsza, L., Roninson, I.B., Sikic, B.I., Twentyman, P.R., Warnke, R., Weinstein, R. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumours: Consensus recommendations. Cancer Research, 56, 3010 3022.
  • 2
    Borg, A.G., Burgess, R., Green, L.M., Scheper, R.J., Liu Yin, J.A. (1998) Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival. British Journal of Haematology, 103, 1083 1091.
  • 3
    Broxterman, H.J., Sonneveld, P., Pieters, R., Lankelma, J., Eekman, C.A., Loonen, A.H., Schoester, M., Ossenkoppele, G.J., Lowenberg, B., Pinedo, H.M., Schuurhuis, G.J. (1999) Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Leukemia, 13, 258 265.
  • 4
    Campos, L., Guyotat, D., Jaffar, C., Solary, E., Archimbaud, E., Treille, D. (1992) Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia. European Journal of Haematology, 48, 254 258.
  • 5
    Del Poeta, G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, F., Masi, M., Tribalto, M., Amadori, S., Papa, G. (1996) Clinical relevance of p-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 1997 2004.
  • 6
    Den Boer, M.L., Pieters, R., Kazemier, K.M., Rottier, M.M., Zwaan, C.M., Kaspers, G.J., Janka-Schaub, G., Henze, G., Creutzig, U., Scheper, R.J., Veerman, A.J. (1998) Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood, 91, 2092 2098.
  • 7
    Filipitis, M., Pohl, G., Stranzl, T., Suchomel, R.W., Scheper, R.J., Jager, U., Geissler, K., Lechner, K., Pirker, R. (1998) Expression of the lung resistance protein predicts poor outcome in the de novo acute myeloid leukemia. Blood, 91, 1508 1513.
  • 8
    Guerci, A., Merlin, J.L., Missoum, N., Feldmann, L., Marchal, S., Witz, F., Rose, C., Guerci, O. (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 85, 2147 2153.
  • 9
    Hart, S.M., Ganeshaguru, K., Scheper, R.J., Prentice, H.G., Hoffbrand, A.V., Mehta, A.B. (1997) Expression of the human major vault protein LRP in acute myeloid leukaemia. Experimental Haematology, 25, 1227 1232.
  • 10
    Hedley, D.W., Xiu-Yan Xie, S., Minden, M.D., Choi, C.H., Chen, H., Ling, V. (1997) A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia. Leukemia, 11, 48 53.
  • 11
    Keizer, H.G., Schuurhuis, G.J., Broxterman, H.J., Lankelma, J., Schoonen, W.G.E.J., Van Rijn, J., Pinedo, H.M., Joenje, H. (1989) Correlation of Multidrug Resistance with decreased drug accumulation, altered subcellular drug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumour cells. Cancer Research, 49, 2988 2993.
  • 12
    Kessel, D., Wilberding, C., Karanes, C., Ratanatharathorn, V. (1984) Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance. Cancer Letters, 24, 305 309.
  • 13
    Kokenberg, E., Sonneveld, P., Sizoo, W., Hagenbeek, A., Lowenberg, B. (1988) Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia. Journal of Clinical Oncology, 6, 802 812.
  • 14
    Krishnamachary, N. & Center, M.S. (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Research, 53, 3658 3661.
  • 15
    Lamy, T., Drenou, B., Grulois, I., Fardel, O., Jacqueline, C., Goasguen, J., Dauriac, C., Amiot, L., Bernard, M., Fauchet, R., Le Prise, P.Y. (1995) Multi-drug resistance (MDR) in leukemia determined by rhodamine 123 efflux assay. Leukemia, 9, 1549 1555.
  • 16
    Lautier, D., Bailly, J.D., Demur, C., Herbert, J.M., Bousquet, C., Laurent, G. (1997) Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells. International Journal of Cancer, 10, 292 299.
  • 17
    Legrand, O., Simonin, G., Perrot, J.Y., Zittoun, R., Marie, J.P. (1998a) Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood, 91, 4480 4488.
  • 18
    Legrand, O., Simonin, R., Zittoun, R., Marie, J-P. (1998b) Lung resistance protein (LRP) gene expression in adult acute myeloid leukaemia: a critical evaluation by three techniques. Leukemia, 12, 1367 1374.
  • 19
    Legrand, O., Zittoun, R., Marie, J-P. (1999) Role of MRP1 in multidrug resistance in acute myeloid leukemia. Leukemia, 13, 578 584.
  • 20
    Leith, C.P., Chen, I.M., Kopecky, K.J., Appelbaum, F.R., Head, F.R., Godwin, J.E., Weick, J.K., William, C.L. (1995) Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: Identification of discordant MDR−/Efflux+ and MDR1+/Efflux− cases. Blood, 6, 2329 2342.
  • 21
    Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R., Willman, C.L. (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study. Blood, 94, 1086 1099.
  • 22
    List, A.F., Spier, C.S., Grogan, T.M., Johnson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J., Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 2464 2469.
  • 23
    Michieli, M., Damiani, D., Ermacora, A., Raspadori, D., Michelutti, A., Grimaz, S., Fanin, R., Russo, D., Lauria, F., Masolini, P., Baccarani, M. (1996) P-glycoprotein (PGP) and lung resistance-related protein (LRP) expression and function in leukaemic blast cells. British Journal of Haematology, 96, 356 365.
  • 24
    Nooter, K., Burger, H., Stoter, G. (1996) Multidrug resistance-associated protein (MRP) in haematological malignancies. Leukemia Lymphoma, 20, 381 387.
  • 25
    Pallis, M. & Russell, N.H. (1998) Functional multidrug resistance in acute myeloblastic leukaemia: a standardised flow cytometric assay for the intracellular daunorubicin accumulation. British Journal of Haematology, 100, 194 197.
  • 26
    Pallis, M., Turzanski, J., Harrison, G., Wheatley, S., Langabeer, A., Burnett, A.K., Russell, N.H. (1999) Use of standardized flow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia. British Journal of Haematology, 104, 307 312.
  • 27
    Pastan, I., Gottesman, M.M., Ueda, K., Lovelace, E., Rutherford, A.V., Willingham, M.C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarised expression of P-glycoprotein in MDCK cells. Proceedings of the National Academy of Science USA, 85, 4486 4490.
  • 28
    Ramu, A., Pollard, H.B., Rosario, L.M. (1989) Doxorubicin resistance in P388 leukemia — evidence for reduced drug influx. International Journal of Cancer, 44, 539 547.
  • 29
    Scheffer, G.L., Wijngaard, P.L.J., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M., Meijer, C.J.L.M., Clevers, H.C., Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578 582.
  • 30
    Sehested, M., Bindslev, N., Demant, E.J., Skovsgaard, T., Jensen, P.B. (1989) Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumour cells. Biochemistry–Pharmacology, 38, 3017 3027.
  • 31
    Slapak, C.A., Mizunuma, N., Kufe, D.E. (1994) Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood, 84, 3113 3121.
  • 32
    Zaman, G.J.R., Flens, M.J., Van Leusden, M.R., De Haas, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J., Borst, P. (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proceedings of the National Academy of Science USA, 91, 8822 8826.
  • 33
    Zhou, D.C., Ramond, S., Viguie, F., Faussat, A.M., Zittoun, R., Marie J.P. (1996) Progressive resistance to homoharringtonine in human myeloleukemia K562 cells: relationship to sequential emergence of MRP and MDR1 gene overexpression and MDR1 gene translation. International Journal of Cancer, 65, 365 371.DOI: 10.1002/(sici)1097-0215(19960126)65:3<365::aid-ijc15>3.0.co;2-9